CN Patent

CN104586850A — 4-[[4-[[4-(2-氰基乙烯基)-2,6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的盐酸盐

Assigned to Janssen Pharmaceutica NV · Expires 2015-05-06 · 11y expired

What this patent protects

本发明涉及包含4-[[4-[[4-(2-氰基乙烯基)-2，6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的盐酸盐作为活性成分的药用组合物及其制备方法。

USPTO Abstract

本发明涉及包含4-[[4-[[4-(2-氰基乙烯基)-2，6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的盐酸盐作为活性成分的药用组合物及其制备方法。

Drugs covered by this patent

rilpivirine-hydrochloride (RILPIVIRINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN104586850A
Jurisdiction: CN
Classification: —
Expires: 2015-05-06
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.